AKT1 and glioblastoma: Our enrichment analysis showed features of synergistic interaction of multiple targets and suggested that targeting the AKT, STAT3, and IKB pathways could alleviate the symptoms of GBM through protein phosphorylation, apoptosis, and inflammatory factors.